Skip to main content
ImmuneCited

Zinc para Upper Respiratory Tract Infections

A

Meta-analysis of 7 trials demonstrates zinc lozenges at 75+ mg/day may reduce cold duration by 33% when started within 24 hours of symptom onset. Zinc acetate lozenges at 80-92 mg/day showed 40% duration reduction. Doses below 75 mg/day showed no effect.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'immunecited.com'; const params = 'ingredient\u003Dzinc\u0026condition\u003Dupper\u002Drespiratory\u002Dinfections'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

A

Conclusión

Meta-analysis of 7 trials demonstrates zinc lozenges at 75+ mg/day may reduce cold duration by 33% when started within 24 hours of symptom onset. Zinc acetate lozenges at 80-92 mg/day showed 40% duration reduction. Doses below 75 mg/day showed no effect.

Key Study Findings

Observational Study n=107 Open-label
Additive effect of free-choice olfactory training combined with pharmacotherapy: A retrospective analysis of post-viral olfactory …
Dose: tokishakuyakusan, zinc sulfate, methylcobalamin vs: medication alone Outcome: olfactory function improvement via T&T olfactometry Efecto: OR=4.96 p=0.009

Población: patients with post-viral olfactory dysfunction (non-COVID)

Review
Exploiting the vulnerability of SARS-CoV-2 with a partnership of mucosal immune function and nutrition: a …
Dose: None vs: None Outcome: None Efecto: None None

Población: None

Review
UCI Sports Nutrition Project: The Role of Nutrition in the Prevention and Management of Illnesses …
Dose: None vs: None Outcome: None Efecto: None None

Población: Elite/professional cyclists nutrition review

Meta-Analysis
Effect of Oral Nutritional Supplementation on Health-Related Outcomes and Nutritional Biomarkers in Children and Adolescents …
Dose: Various oral nutritional supplements vs: Standard diet or placebo Outcome: Health outcomes and nutritional biomarkers Efecto: None None

Población: Children/adolescents with undernutrition

Controlled Clinical Trial n=120 5 weeks Single-blind
Single-Center-Single-Blinded Clinical Trial to Evaluate the Efficacy of a Nutraceutical Containing Boswellia Serrata, Bromelain, Zinc, …
Dose: 20 or 30 days treatment vs: Standard treatment only (nasal aerosol) Outcome: Otoscopy, impedance, fibroscopy, pure auditory test Efecto: None None

Población: Children with otitis media

Review
Associations of fine particulate matter and constituents with pediatric emergency room visits for respiratory diseases …
Dose: 31 μg vs: None Outcome: None Efecto: None None

Población: respiratory disease

Key Statistics

15

Estudios

1500

Participantes

Positive

A

Calificación

Referenced Papers

Pakistan journal of … 2013 33 citas
Acta scientiarum polonorum. … 2012 11 citas
American family physician 2012
International journal of … 2011 49 citas
Nihon Jibiinkoka Gakkai … 2009 1 citas
The Cochrane database … 2007 24 citas
Clinical evidence 2003
Clinical evidence 2003
American family physician 2002
Canadian journal of … 2001 72 citas
Zinc for the common cold. Systematic Review
The Cochrane database … 2000 294 citas
European journal of … 1996 54 citas
Nederlands tijdschrift voor … 1991
Clinica chimica acta; … 1986 15 citas
Southern medical journal 1978 3 citas

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Dosificaciones de uso común

general:
8-11 mg/day
coldtreatment:
75-100 mg/day elemental zinc (lozenges, within 24h of onset, up to 2 weeks)
immunesupport:
15-30 mg/day

Límite superior: 40 mg/day (long-term)

Dosificaciones estudiadas en la investigación

Dosificación Duración Efecto N
tokishakuyakusan, zinc sulfate, methylcobalamin -- Positive 107
None -- Mixed --
None -- Mixed --
Various oral nutritional supplements -- Positive --
20 or 30 days treatment 5 weeks Positive 120
31 μg -- Neutral --
94.57% -- Mixed --
None -- Mixed 387

Mejor momento para tomar: Lozenges: dissolve slowly in mouth every 2-3h at cold onset; Supplements: with food to minimize nausea

Safety & Side Effects

Efectos secundarios reportados

  • Nausea and vomiting (especially on an empty stomach)
  • Metallic taste in the mouth
  • Copper depletion with chronic high-dose use (>40 mg/day)
  • Headache and diarrhea

Interacciones conocidas

  • Copper supplements (zinc inhibits copper absorption at doses >40 mg/day)
  • Tetracycline and quinolone antibiotics (mutual absorption reduction)
  • Penicillamine (zinc reduces absorption of this rheumatoid arthritis drug)
  • Iron supplements (mutual absorption interference when taken together)

Ingesta máxima tolerable: 40 mg/day (long-term)

Consulte siempre a su profesional de salud antes de comenzar cualquier suplemento.Siempre consulte a su profesional de salud antes de comenzar cualquier suplemento.

Frequently Asked Questions

Does Zinc help with Upper Respiratory Tract Infections?
Based on 15 studies with 1,500 participants, there is strong evidence from multiple clinical trials that Zinc may support Upper Respiratory Tract Infections management. Our evidence grade is A (Strong Evidence).
How much Zinc should I take for Upper Respiratory Tract Infections?
Studies have used various dosages. A commonly studied range is 8-11 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Zinc?
Reported side effects may include Nausea and vomiting (especially on an empty stomach), Metallic taste in the mouth, Copper depletion with chronic high-dose use (>40 mg/day), Headache and diarrhea. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Zinc and Upper Respiratory Tract Infections?
We rate the evidence as Grade A (Strong Evidence). This rating is based on 15 peer-reviewed studies with 1,500 total participants. The overall direction of effect is positive.

Related Evidence

Otros ingredientes para Upper Respiratory Tract Infections

Aviso legal FDA: Estas declaraciones no han sido evaluadas por la Food and Drug Administration. Los productos y la información en este sitio web no están destinados a diagnosticar, tratar, curar ni prevenir ninguna enfermedad. Las calificaciones de evidencia presentadas se basan en nuestro análisis de investigación publicada revisada por pares y no constituyen consejo médico. Siempre consulte a su profesional de salud antes de comenzar cualquier régimen de suplementos.